CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 39 filers reported holding CRISPR THERAPEUTICS AG in Q2 2017. The put-call ratio across all filers is 106.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,243 | -17.1% | 5,237 | -3.6% | 0.00% | – |
| Q2 2023 | $322,187 | +21.6% | 5,435 | +39.2% | 0.00% | – |
| Q3 2022 | $265,000 | -15.3% | 3,904 | -7.3% | 0.00% | – |
| Q2 2022 | $313,000 | -96.0% | 4,213 | -96.5% | 0.00% | -100.0% |
| Q1 2022 | $7,745,000 | +1850.9% | 119,955 | +2322.4% | 0.00% | – |
| Q4 2021 | $397,000 | -4.6% | 4,952 | +34.0% | 0.00% | – |
| Q3 2021 | $416,000 | +7.5% | 3,696 | +39.3% | 0.00% | – |
| Q2 2021 | $387,000 | +126.3% | 2,654 | +86.6% | 0.00% | – |
| Q1 2021 | $171,000 | -59.6% | 1,422 | -36.5% | 0.00% | – |
| Q4 2020 | $423,000 | +10475.0% | 2,238 | +4562.5% | 0.00% | – |
| Q3 2020 | $4,000 | -95.6% | 48 | -95.0% | 0.00% | – |
| Q2 2020 | $90,000 | -3.2% | 957 | -59.5% | 0.00% | – |
| Q1 2020 | $93,000 | -97.2% | 2,364 | -95.7% | 0.00% | -100.0% |
| Q4 2019 | $3,357,000 | -6.6% | 55,114 | -37.1% | 0.00% | -33.3% |
| Q3 2019 | $3,595,000 | -35.0% | 87,680 | -25.3% | 0.00% | -25.0% |
| Q2 2019 | $5,528,000 | +61.2% | 117,360 | +22.2% | 0.00% | +33.3% |
| Q1 2019 | $3,429,000 | +27.2% | 96,010 | +1.8% | 0.00% | 0.0% |
| Q4 2018 | $2,695,000 | -39.2% | 94,320 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $4,432,000 | -18.5% | 99,933 | +7.9% | 0.00% | -25.0% |
| Q2 2018 | $5,440,000 | +166.0% | 92,583 | +107.0% | 0.00% | +100.0% |
| Q1 2018 | $2,045,000 | +4444.4% | 44,733 | +2208.2% | 0.00% | – |
| Q4 2017 | $45,000 | +32.4% | 1,938 | 0.0% | 0.00% | – |
| Q3 2017 | $34,000 | +30.8% | 1,938 | +18.3% | 0.00% | – |
| Q2 2017 | $26,000 | -27.8% | 1,638 | 0.0% | 0.00% | – |
| Q1 2017 | $36,000 | – | 1,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |